Narrative review / 2008
Evidence on dietary phytoestrogens and breast cancer risk or recurrence remains unclear and insufficient for clinical guidelines.
This review examines human observational and intervention studies assessing dietary isoflavone and lignan exposure in relation to breast cancer risk and survival. Observational studies suggest a protective effect of isoflavones on breast cancer risk, with inconsistent evidence for lignans. Conversely, short-term intervention studies indicate a possible stimulatory effect on breast tissue, prompting concerns about potential adverse effects in breast cancer patients. Due to a dearth of human studies addressing recurrence and survival, insufficient evidence exists to guide clinical use.
Shows an association, not proof of cause and effect.
- Study type
- Narrative review
- Who was studied
- Human populations from observational and intervention studies
- What was measured
- Breast cancer risk, breast tissue stimulation, recurrence, and survival
THE PAPER
Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know.
Velentzis LS, Woodside JV, Cantwell MM, Leathem AJ, Keshtgar MR. Eur J Cancer, 2008.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.